Taengsakul N, Nivatpumin P, Chotchutipan T, Tungfung S
PLoS One. 2025; 20(1):e0314861.
PMID: 39883632
PMC: 11781643.
DOI: 10.1371/journal.pone.0314861.
Kassem M, Nies K, Boswijk E, van der Pol J, Aizaz M, Gijbels M
Front Cardiovasc Med. 2023; 10:1227495.
PMID: 37680565
PMC: 10481960.
DOI: 10.3389/fcvm.2023.1227495.
Watase H, Shen M, Sui B, Gao P, Zhang D, Sun J
Stroke Vasc Neurol. 2020; 6(1):25-32.
PMID: 32792458
PMC: 8005910.
DOI: 10.1136/svn-2020-000370.
Han T, Paramsothy P, Hong J, Isquith D, Xu D, Bai H
Int J Cardiovasc Imaging. 2020; 36(3):481-489.
PMID: 32020410
DOI: 10.1007/s10554-019-01600-1.
Watase H, Sun J, Hippe D, Balu N, Li F, Zhao X
Arterioscler Thromb Vasc Biol. 2018; 38(4):927-934.
PMID: 29472231
PMC: 5965674.
DOI: 10.1161/ATVBAHA.117.310296.
Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events-design and rationale.
Zhao X, Li R, Hippe D, Hatsukami T, Yuan C
Stroke Vasc Neurol. 2017; 2(1):15-20.
PMID: 28959486
PMC: 5435211.
DOI: 10.1136/svn-2016-000053.
Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus.
Sun B, Li X, Liu X, Ge X, Lu Q, Zhao X
Cardiovasc Diabetol. 2017; 16(1):111.
PMID: 28893252
PMC: 5594451.
DOI: 10.1186/s12933-017-0592-9.
Advantage in Bright-blood and Black-blood Magnetic Resonance Imaging with High-resolution for Analysis of Carotid Atherosclerotic Plaques.
Li M, Le W, Tao X, Li M, Li Y, Qu N
Chin Med J (Engl). 2015; 128(18):2478-84.
PMID: 26365966
PMC: 4725549.
DOI: 10.4103/0366-6999.164933.
Intra-individual comparison of carotid and femoral atherosclerotic plaque features with in vivo MR plaque imaging.
Helck A, Bianda N, Canton G, Yuan C, Hippe D, Reiser M
Int J Cardiovasc Imaging. 2015; 31(8):1611-8.
PMID: 26296806
DOI: 10.1007/s10554-015-0737-4.
Clinical value of black-blood high-resolution magnetic resonance imaging for intracranial atherosclerotic plaques.
Yang H, Zhu Y, Geng Z, Li C, Zhou L, Liu Q
Exp Ther Med. 2015; 10(1):231-236.
PMID: 26170940
PMC: 4486879.
DOI: 10.3892/etm.2015.2469.
Advances in MRI for the evaluation of carotid atherosclerosis.
Makris G, Teng Z, Patterson A, Lin J, Young V, Graves M
Br J Radiol. 2015; 88(1052):20140282.
PMID: 25826233
PMC: 4651390.
DOI: 10.1259/bjr.20140282.
Computed tomography angiography vs 3 T black-blood cardiovascular magnetic resonance for identification of symptomatic carotid plaques.
Grimm J, Schindler A, Schwarz F, Cyran C, Bayer-Karpinska A, Freilinger T
J Cardiovasc Magn Reson. 2014; 16:84.
PMID: 25315518
PMC: 4189681.
DOI: 10.1186/s12968-014-0084-y.
Clinical factors associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with established vascular disease (from the AIM-HIGH Study).
Zhao X, Hatsukami T, Hippe D, Sun J, Balu N, Isquith D
Am J Cardiol. 2014; 114(9):1412-9.
PMID: 25245415
PMC: 4195846.
DOI: 10.1016/j.amjcard.2014.08.001.
Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.
Du R, Cai J, Zhao X, Wang Q, Liu D, Leng W
BMC Cardiovasc Disord. 2014; 14:83.
PMID: 25022285
PMC: 4107586.
DOI: 10.1186/1471-2261-14-83.
Impact of coexisting coronary artery disease on the occurrence of cerebral ischemic lesions after carotid stenting.
Huang K, Chang Y, Chang C, Chang T, Liu C, Hsieh I
PLoS One. 2014; 9(4):e94280.
PMID: 24732408
PMC: 3986076.
DOI: 10.1371/journal.pone.0094280.
Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.
Zhao X, Kerwin W
Clin Lipidol. 2012; 7(3):329-343.
PMID: 23197995
PMC: 3506125.
DOI: 10.2217/clp.12.33.
MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease.
Degnan A, Gallagher G, Teng Z, Lu J, Liu Q, Gillard J
AJNR Am J Neuroradiol. 2011; 33(8):1427-35.
PMID: 21940802
PMC: 7966534.
DOI: 10.3174/ajnr.A2697.
MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.
Zhao X, Dong L, Hatsukami T, Phan B, Chu B, Moore A
JACC Cardiovasc Imaging. 2011; 4(9):977-86.
PMID: 21920335
PMC: 3638021.
DOI: 10.1016/j.jcmg.2011.06.013.
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Fayad Z, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J
Am Heart J. 2011; 162(2):214-221.e2.
PMID: 21835280
PMC: 4047820.
DOI: 10.1016/j.ahj.2011.05.006.
Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke.
Yazdani S, Vorpahl M, Ladich E, Virmani R
Curr Treat Options Cardiovasc Med. 2010; 12(3):297-314.
PMID: 20842549
DOI: 10.1007/s11936-010-0074-9.